Skip to content
NovaZone Flow

The Zimbabwean Government Turns Down ‘Unbalanced’ US Healthcare Assistance Agreement Over Information Concerns

Medical aid illustration
The proposed US funding was aimed at initiatives for treating and preventing HIV/Aids, tuberculosis, and malaria.

Zimbabwe has rejected a major US health deal worth $367m (272 million pounds) spanning five years due to Washington's request for sensitive data.

This rejection became public following a government memo from December was disclosed, which showed Head of State Emmerson Mnangagwa believed the arrangement was "unbalanced".

A government spokesman later clarified that the United States was demanding access to genetic material for research and commercial purposes but refused to guarantee the resulting advantages from future vaccines.

"We are forced to start the challenging and unfortunate process of winding down our health assistance in Zimbabwe," remarked US ambassador to Zimbabwe Pamela Tremont in a statement.

The US Embassy said the US had provided over $1.9bn in health funding to Zimbabwe during the past twenty years.

A medical body in Zimbabwe has urged more talks to secure a deal acceptable to all parties so the country's vital HIV programme can continue.

Broader Context

Zimbabwe's decision comes after a similar situation in Kenya, where a high court blocked a related health funding agreement following concerns were raised about the safety of Kenyans' health data.

Since returning to the presidency last year, US President Donald Trump has drastically cut overseas assistance and shut down the key foreign aid agency.

The agency had overseen assistance for the US government, but Trump argued its spending was "wasteful" and his government was pursuing direct bilateral agreements to enhance openness and accountability.

According to reports, Sixteen African countries have to date signed similar agreements, representing more than $18.3bn in new funding.

Details of the Declined Deal

The money for Zimbabwe was intended to funded "HIV/Aids treatment and prevention, TB, malaria, maternal and child health, and preparing for epidemics".

"It is our view this cooperation could have provided significant advantages for the people of Zimbabwe, particularly the 1.2 million currently on HIV treatment through US-supported programmes," Tremont said.

However, government spokesperson Nick Mangwana said the proposed deal was "unequal".

"Our nation was requested to provide its biological resources and data for a long time, with no equivalent guarantee of access to any scientific breakthroughs – such as vaccines, diagnostics, or treatments – that might be developed from that shared data," his statement read.

"In essence, our country would supply the raw materials for scientific discovery with no assurance that the final treatments would be accessible to our population should a future health crisis arise."

National Interest and International Frameworks

He also pointed out that the US's withdrawal from the global health body and its pursuit of bilateral health agreements were disrupting systems already established through the international health agency.

The spokesperson cited its Pathogen Access and Benefit Sharing scheme created to deal with future global health emergencies.

"This system is designed to guarantee that when a nation provides its samples, the resulting advantages – such as vaccines and treatments – are distributed fairly, not commercialised solely by those with the capability to develop them."

These objections over the US deal "are not meant as hostility towards the US," he added.

"We encourage continued dialogue with our American counterparts on how subsequent co-operation might be designed in a manner that honours the sovereignty and interests of both nations."

Medical Community Reaction

The Zimbabwe College of Public Health Physicians (ZCPHP) said it acknowledged the official position, but urged that talks need to persist given that much of the country's Aids initiatives were funded by international support.

"In cases where technical issues exist, including those involving data governance or agreement terms, these can often be resolved through detailed discussion and negotiated safeguards," the group commented.

The halted deal highlights the complex challenges between receiving crucial international aid and protecting a country's data in an increasingly data-driven world.

The writer

Angela Cuevas

Lena is a digital wellness advocate and writer exploring the intersection of technology and mindfulness.

NovaZone Flow

Type to search articles.